IL162434A0 - Treatment of glioblastoma with thymosin-alpha 1 - Google Patents

Treatment of glioblastoma with thymosin-alpha 1

Info

Publication number: IL162434A0
Authority: IL; Israel
Prior art keywords: thymosin; glioblastoma; treatment; alpha; alpha1
Prior art date: 2001-12-10

Application number

IL16243402A

Other languages

English (en)

Original Assignee

Rhode Island Hospital

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-10

Filing date

2002-12-10

Publication date

2005-11-20

2002-12-10 Application filed by Rhode Island Hospital filed Critical Rhode Island Hospital

2005-11-20 Publication of IL162434A0 publication Critical patent/IL162434A0/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
- A61K31/175—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2292—Thymosin; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Endocrinology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Prostheses (AREA)

IL16243402A 2001-12-10 2002-12-10 Treatment of glioblastoma with thymosin-alpha 1 IL162434A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US33714901P	2001-12-10	2001-12-10
PCT/US2002/039329 WO2003049697A2 (en)	2001-12-10	2002-12-10	Treatment of glioblastoma with thymosin-alpha 1

Publications (1)

Publication Number	Publication Date
IL162434A0 true IL162434A0 (en)	2005-11-20

Family

ID=23319320

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL16243402A IL162434A0 (en)	2001-12-10	2002-12-10	Treatment of glioblastoma with thymosin-alpha 1

Country Status (22)

Country	Link
US (1)	US20060166870A1 (xx)
EP (1)	EP1461063B1 (xx)
JP (1)	JP2005516910A (xx)
KR (2)	KR20040091611A (xx)
CN (1)	CN1615147A (xx)
AT (1)	ATE356628T1 (xx)
AU (1)	AU2002357115B2 (xx)
BR (1)	BR0214848A (xx)
CA (1)	CA2469595A1 (xx)
DE (1)	DE60218896T2 (xx)
DK (1)	DK1461063T3 (xx)
EA (1)	EA005822B1 (xx)
ES (1)	ES2283653T3 (xx)
IL (1)	IL162434A0 (xx)
MX (1)	MXPA04005585A (xx)
NO (1)	NO20042927L (xx)
NZ (1)	NZ533942A (xx)
PL (1)	PL370829A1 (xx)
PT (1)	PT1461063E (xx)
SI (1)	SI1461063T1 (xx)
UA (1)	UA77999C2 (xx)
WO (1)	WO2003049697A2 (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2288118B1 (es)	2006-05-10	2008-11-01	Bcn Peptides, S.A.	Procedimiento para sintetizar timosinas.
CN108226016A (zh) *	2018-01-12	2018-06-29	浙江普罗亭健康科技有限公司	肿瘤免疫细胞亚群精准分型的质谱流式检测试剂盒
CN112147326B (zh) *	2020-09-04	2022-04-08	北京大学	一种肿瘤免疫细胞亚群分型精准检测试剂盒

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4079127A (en) *	1976-10-28	1978-03-14	Board Of Regents Of The University Of Texas	Thymosin alpha 1
US4116951A (en) *	1977-04-22	1978-09-26	Hoffmann-La Roche Inc.	[Asn2 ]-thymosin α1 and analogs thereof
US4148786A (en) *	1978-06-26	1979-04-10	American Home Products Corporation	Analgesic polypeptide
DE2919592A1 (de) *	1979-05-15	1981-01-15	Max Planck Gesellschaft	Verfahren zur herstellung von thymosin- alpha 1 und derivaten davon
IT1238231B (it) *	1989-12-18	1993-07-12	Consiglio Nazionale Ricerche	Impiego di immunomodulanti come agenti sinergici di chemioterapici nella terapia dei tumori
FR2793684B1 (fr) *	1999-05-17	2001-08-10	Ethypharm Lab Prod Ethiques	Utilisation de microspheres biodegradables liberant un agent anticancereux pour le traitement du glioblastome, procede de preparation de ces microspheres et suspension les contenant
US6462017B1 (en) *	2000-05-01	2002-10-08	Sciclone Pharmaceuticals, Inc.	Method of reducing side effects of chemotherapy in cancer patients

2002
- 2002-10-12 UA UA20040705523A patent/UA77999C2/uk unknown
- 2002-12-10 DK DK02804755T patent/DK1461063T3/da active
- 2002-12-10 SI SI200230509T patent/SI1461063T1/sl unknown
- 2002-12-10 IL IL16243402A patent/IL162434A0/xx unknown
- 2002-12-10 JP JP2003550748A patent/JP2005516910A/ja active Pending
- 2002-12-10 AU AU2002357115A patent/AU2002357115B2/en not_active Ceased
- 2002-12-10 US US10/498,050 patent/US20060166870A1/en not_active Abandoned
- 2002-12-10 EA EA200400755A patent/EA005822B1/ru not_active IP Right Cessation
- 2002-12-10 DE DE60218896T patent/DE60218896T2/de not_active Expired - Lifetime
- 2002-12-10 KR KR10-2004-7008939A patent/KR20040091611A/ko not_active Application Discontinuation
- 2002-12-10 PT PT02804755T patent/PT1461063E/pt unknown
- 2002-12-10 PL PL02370829A patent/PL370829A1/xx not_active Application Discontinuation
- 2002-12-10 NZ NZ533942A patent/NZ533942A/en unknown
- 2002-12-10 CA CA002469595A patent/CA2469595A1/en not_active Abandoned
- 2002-12-10 CN CNA028270819A patent/CN1615147A/zh active Pending
- 2002-12-10 AT AT02804755T patent/ATE356628T1/de active
- 2002-12-10 ES ES02804755T patent/ES2283653T3/es not_active Expired - Lifetime
- 2002-12-10 MX MXPA04005585A patent/MXPA04005585A/es active IP Right Grant
- 2002-12-10 WO PCT/US2002/039329 patent/WO2003049697A2/en active Application Filing
- 2002-12-10 BR BR0214848-0A patent/BR0214848A/pt not_active IP Right Cessation
- 2002-12-10 KR KR1020107002516A patent/KR20100029844A/ko not_active Application Discontinuation
- 2002-12-10 EP EP02804755A patent/EP1461063B1/en not_active Expired - Lifetime
2004
- 2004-07-08 NO NO20042927A patent/NO20042927L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
NZ533942A (en)	2007-01-26
EP1461063B1 (en)	2007-03-14
DE60218896T2 (de)	2007-09-20
CA2469595A1 (en)	2003-06-19
EA200400755A1 (ru)	2004-12-30
DK1461063T3 (da)	2007-05-21
EA005822B1 (ru)	2005-06-30
SI1461063T1 (sl)	2007-08-31
WO2003049697A2 (en)	2003-06-19
KR20040091611A (ko)	2004-10-28
WO2003049697A3 (en)	2004-01-15
NO20042927L (no)	2004-09-09
EP1461063A4 (en)	2005-08-31
BR0214848A (pt)	2004-11-09
US20060166870A1 (en)	2006-07-27
AU2002357115A1 (en)	2003-06-23
PT1461063E (pt)	2007-06-18
EP1461063A2 (en)	2004-09-29
ES2283653T3 (es)	2007-11-01
ATE356628T1 (de)	2007-04-15
MXPA04005585A (es)	2005-03-23
CN1615147A (zh)	2005-05-11
PL370829A1 (en)	2005-05-30
DE60218896D1 (de)	2007-04-26
AU2002357115B2 (en)	2007-12-13
KR20100029844A (ko)	2010-03-17
JP2005516910A (ja)	2005-06-09
UA77999C2 (en)	2007-02-15

Publication	Publication Date	Title
MY135766A (en)	2008-06-30	Quinolinones and naphthyridinones for treating inflammatory diseases
CY1107531T1 (el)	2013-03-13	Χρηση αναστολεων πρωτεασομης για την αγωγη των διαταραχων ξηρου οφθαλμου
DE60112974D1 (en)	2005-09-29	Carbolinderivate
MXPA02011411A (es)	2003-04-25	Inhibidores de proteasa de serina.
DE60216233D1 (en)	2007-01-04	Carbolinderivate
DE60042401D1 (de)	2009-07-30	Fab-i inhibitoren
DE60105418D1 (de)	2004-10-14	Serinprotease-inhibitoren
GB0011358D0 (en)	2000-06-28	Novel use
MXPA00012685A (es)	2003-09-10	Oregano para el tratamiento de parasitos internos y protozoarios.
UY27203A1 (es)	2002-10-31	Bencimidazoles útiles en el tratamiento de la disfunción sexual
MXPA03001643A (es)	2004-05-14	Composiciones y metodos para el diagnostico y tratamiento de tumores.
BR0210101A (pt)	2004-06-08	Combinações antineoplásticas
DE60127131D1 (de)	2007-04-19	Tricyclische imidazopyridine
FI20000635A0 (fi)	2000-03-17	COMT-inhibiittoreiden käyttö analgeettina
SI1377574T1 (xx)	2005-08-31
CY1107343T1 (el)	2012-12-19	ΕΝΑ ΠΡΟΪΟΝ ΣΥΝΔΥΑΣΜΟΥ ΠΟΥ ΠEPΙΛΑΜΒΑΝΕΙ ΜΕΛΑΓΑΤΡΑΝΗ ΚΑΙ ΕΝΑΝ ΑΝΑΣΤΟΛΕΑ ΠΑΡΑΓΟΝΤΑ VIIa
IL162434A0 (en)	2005-11-20	Treatment of glioblastoma with thymosin-alpha 1
SE0302361D0 (sv)	2003-09-03	Inhibering av upptagning av monoamin
EA200200853A1 (ru)	2003-02-27	Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака
TR200200169T2 (tr)	2002-06-21	IL-18 inhibitörlerinin kullanımı.
IL139144A0 (en)	2001-11-25	Mycobacterial inhibitors
PT1042288E (pt)	2008-03-11	Inibidores de tripeptidil peptidase
ZA200209835B (en)	2003-12-04	Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or anti-metabolites.
MXPA03001644A (es)	2004-05-14	Composiciones y metodos para el diagnostico y tratamiento de tumor.
TR200003084T2 (tr)	2001-02-21	Paroxetine askorbat